Therapy and prophylaxis of deep vein thrombosis and pulmonary embolism in gynecology and obstetrics;Terapija I profilaksa duboke venske tromboze i plućne embolije u ginekologiji i opstetriciji

Acta Medica Croatica

Volumn 57, Issue 2, 2003, Pages 123-130

  Vučić, Nikša ^a   Čala, Krešimir ^a   Rančić, Iva ^a   Ptičar, Romana ^a  

^a Croatian Academy of Medical Sciences   (Croatia)

Author keywords

Colour doppler; Deep vein thrombosis; Heparin; Pregnancy; Prophylaxis

Indexed keywords

D DIMER; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BLEEDING; BLOOD CLOTTING; DEEP VEIN THROMBOSIS; GYNECOLOGY; HUMAN; LUNG EMBOLISM; OBSTETRICS; OSTEOPOROSIS; PATIENT CODING; PREGNANCY; REVIEW; RISK FACTOR; THROMBOCYTOPENIA;

ADULT; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 0038001537     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Kierkegaard A. Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Obstet Gynecol Scand 1983; 62: 239-43.
2. Treffers PE, Huidekoper BL, Weenink GH, Kloosterman GJ. Epidemiological observations of thrombo-embolic disease during pregnancy and in the puerperium, in 56,022 women. Int J Gynaecol Obstet 1983; 21: 327-31.
3. Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 1998; 114: Suppl: 524S-530S.
4. Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. J Clin Pathol 1993; 46: 489-96.
5. Tengborn L, Bergqvist D, Matzsch T, Bergqvist A, Hedner U. Recurrent thromboembolism in pregnancy and puerperium: is there a need for thromboprophylaxis? Am J Obstet Gynecol 1989; 160: 90-4.
6. Anderson FAJr, Wheeler HB, Goldberg RJ i sur. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 1991; 151: 933-8.
7. Carter CJ. The natural history and epidemiology of venous thrombosis. Prog Cardiovasc Dis 1994; 36: 423-38.
8. Prevention of venous thrombosis and pulmonary embolism: NIH Consensus Development. JAMA 1986; 256: 744-9.
9. Clarke-Pearson DL. Prevention of venous thromboembolism in gynecologic surgery patients. Curr Opin Obstet Gynecol 1993; 5: 73-9.
10. Ginsberg JS. Management of venous thromboembolism. N Engl J Med 1996; 335: 1816-28.
11. Colman RW, Hirsch J, Marder VJ, Salzman EW, ur. Hemostasis and thrombosis: basic principles and clinical practice. 3. izd. Philadelphia: J. B. Lippincott, 1994, 1283-4.
12. Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc Res 1973; 5: 167-79.
13. Brinkhous KM, Smith HP, Warner ED i sur. The inhibition of blood clotting: an unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin into thrombin. Am J Physiol 1939; 125: 683-7.
14. Dizon-Townson DS, Nelson LM, Jang H, Varner MW, Ward K. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Am J Obstet Gynecol 1997; 176: 883-6.
15. Hallak M, Senderowicz J, Cassel A i sur. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy. Am J Obstet Gynecol 1997; 176: 889-93.
16. Jordan FLj, Nandorff F. The familial tendency in thromboembolic disease. Acta Med Scand 1956; 156: 267-75.
17. Hirsh J, Prins MN, Samama M. Approach to the thrombophilic patient. U: Colman RW, Hirsh J, Marder VJ, Salzman EW, ur. Hemostasis and thrombosis: basic principles and clinical practice. 3. izd. Philadelphia: JB Lippincott, 1994, 1543-61.
18. Rose SC, Zwiebel WJ, Nelson BD i sur. Symptomatic lower extremity deep venous thrombosis: accuracy, limitations, and role of color duplex flow imaging in diagnosis. Radiology 1990; 175: 639-44.
19. Wells PS, Hirsh J, Anderson DR i sur. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345: 1326-30.
20. Bames RW, Wu KK, Hoak JC. Fallibility of the clinical diagnosis of venous thrombosis. JAMA 1975; 234: 605-7.
21. Chance JF, Abbitt PL, Tegtmeyer CJ, Powers RD. Real-time ultrasound for the detection of deep vein thrombosis. Ann Emerg Med 1991; 20: 494-6.
22. Baxter GM, McKechnie S, Duffy P. Colour Doppler ultrasound in deep venous thrombosis: a comparison with venography. Clin Radiol 1990; 42: 32-6.
23. Mitchell DC, Grasty MS, Stebbings WS i sur. Comparison of duplex ultrasonography and venography in the diagnosis of deep venous thrombosis. Br J Surg 1991; 78: 611-3.
24. Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 1994; 71: 1-6.
25. Wells PS, Hirsh J, Anderson DR i sur. Comparison of the accuracy of impedance plethysmography and compression ultrasonography in outpatients with clinically suspected deep vein thrombosis: a two centre paired-design prospective trial. Thromb Haemost 1995; 74: 1423-7.
26. Flanc C, Kakkar VV, Clarke MB. The detection of venous thrombosis of the legs using 125I-labelled fibrinogen. Br J Surg 1968; 55: 742-7.
27. Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972; 104: 134-44.
28. Wilson JE, Bynum Lj, Parkey RW. Heparin therapy in venous thromboembolism. Am J Med 1981; 70: 808-16.
29. Fagher B, Lundh B. Heparin treatment of deep vein thrombosis: effects and complications after continuous or intermittent heparin administration. Acta Med Scand 1981; 210: 357-61.
30. Andersson G, Fagrell B, Holmgren K i sur. Subcutaneous administration of heparin: a randomised comparison with intravenous administration of heparin to patients with deep vein thrombosis. Thromb Res 1982; 27: 631-9.
31. Hull RD, Raskob GE, Hirsh J i sur. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 1986; 315: 1109-14.
32. Pini M, Pattachini C, Quintavalla R i sur. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis: a randomized clinical trial. Thromb Haemost 1990; 64: 222-6.
33. Glazier RL, Corwell EB. Randomized prospective trial of continuous vs intermittent heparin therapy. JAMA 1976; 236: 1365-7.
34. Gould MK, Dembitzer AD, Doyle RL i sur. Low molecular weight heparins compared with unfractionated heparin for the treatment of acute deep venous thrombosis: a meta-analysis of randomized controlled trials. Ann Intern Med 1999; 130: 800-9.
35. Basu D, Gallus A, Hirsh J i sur. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 1972; 287: 324-7.
36. Brill-Edwards P, Ginsberg JS, Johnston M i sur. Establishing a therapeutic range for heparin therapy. Ann Intern Med 1993; 119: 104-9.
37. Cruickshank MK, Levine MN, Hirsh J i sur. A standard heparin nomogram for the management of heparin therapy. Arch Intern Med 1991; 151: 333-7.
38. Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Lancet 1992; 340: 873-6.
39. Kniemeyer HW, Sandmann W, Schwindt C, Grabitz K, Torsello G, Stuhmeier K. Thrombectomy with arteriovenous fistula for embolizing deep venous thrombosis: an alternative therapy for prevention of recurrent pulmonary embolism. Clin Invest 1993; 72: 40-5.
40. Walsh JJ, Bonnar J, Wright FW. A study of pulmonary embolism and deep leg vein thrombosis after major gynaecological surgery using labelled fibrinogen-phlebography and lung scanning. J Obstet Gynaecol Br Commonw 1974; 81: 311-6.
41. Clarke-Pearson DL. Prevention of venous thromboembolism in gynecologic surgery patients. Curr Opin Obstet Gynecol 1993; 5: 73-9.
42. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988; 318: 1162-73.
43. Clarke-Pearson DL, Coleman RE, Synan IS, Hinshaw W, Creasman WT. Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin. Am J Obstet Gynecol 1983; 145: 606-13.
44. Clarke-Pearson DL, DeLong E, Synan IS, Soper JT, Creasman WT, Coleman RE. A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis. Obstet Gynecol 1990; 75: 684-9.
45. Ballard RM, Bradley-Watson PJ, Johnstone FD, Kenney A, McCarthy TG. Low doses of subcutaneous heparin in the prevention of deep vein thrombosis after gynaecological surgery. J Obstet Gynaecol Br Commonw 1973; 180: 469-72.
46. Kakkar VV, Corrigan TP, Fossard DP. Prevention of fatal postoperative pulmonary embolism by low doses of heparin: an international multicentre trial. Lancet 1975; 2: 45-51.
47. Fejgin MD, Lourwood DL. Low molecular weight heparins and their use in obstetrics and gynecology. Obstet Gynecol Surv 1994; 49: 424-31.
48. Borstad E, Urdal K, Handeland G, Abildgaard U. Comparison of low molecular weight heparin vs unfractionated heparin in gynecological surgery. Acta Obstet Gynecol Scand 1988; 67: 99-103.
49. Borstad E, Urdal K, Handeland G, Abildgaard U. Comparison of low molecular weight heparin vs unfractionated heparin in gynecologic surgery. II. Reduced dose of low molecular weight heparin. Acta Obstet Gynecol Scand 1992; 71: 471-5.
50. Clarke-Pearson DL, DeLong ER, Synan IS, Creasman WT. Complications of low-dose heparin prophylaxis in gynecologic oncology surgery. Obstet Gynecol 1984; 64: 689-93.
51. Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993; 168: 1265-70.
52. Dahlman TC, Lindvall N, Hellgren M. Osteopenia in pregnancy during long-term heparin treatment: a radiological study post partum. Br J Obstet Gynaecol 1990; 97: 221-8.
53. Crandon AJ, Koutts J. Incidence of postoperative deep vein thrombosis in gynaecological oncology. Aust N Z J Obstet Gynaecol 1983; 23: 216-9.
54. Clarke-Pearson DL, DeLong ER, Synan IS, Coleman RE, Creasman WT. Variables associated with postoperative deep venous thrombosis: a prospective study of 411 gynecology patients and creation of a prognostic model. Obstet Gynecol 1987; 69: 146-50.
55. Sevitt S, Gallagher N. Venous thrombosis and pulmonary embolism. Br J Surg 1961; 48: 475-89.
56. Beguin S, Lindhout T, Hemker HC. The mode of action of heparin in plasma. Thromb Haemost. 1988; 60: 457-462.
57. Lindahl U, Backstrom G, Hook M i sur. Structure of the antithrombin-binding site of heparin. Proc Natl Acad Sci USA 1979; 76: 3198-3202.
58. Salzman EW, Deykin D, Shapiro RM i sur. Management of heparin therapy: controlled prospective trial. N Engl J Med 1975; 292: 1046-50.
59. Hirsh J, van Aken WG, Gallus AS i sur. Heparin kinetics in venous thrombosis and pulmonary embolism. Circulation 1976; 53: 691-5.
60. de Swart CA, Nijmeyer B, Roelofs JM i sur. Kinetics of intravenously administered heparin in normal humans. Blood 1982; 60: 1251-8.
61. Bara L, Billaud E, Gramond G i sur. Comparative pharmacokinetics of low molecular weight heparin (PK 10169) and unfractionated heparin after intravenous and subcutaneous administration. Thromb Res 1985; 39: 631-6.
62. Hirsh J, Warkentin TE, Raschke R i sur. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1998; 114: 489S-510S.
63. Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992; 79: 1-17.
64. Esquivel CO, Bergqvist D, Bjorck CG i sur. Comparison between commercial heparin, low-molecular weight heparin and pentosan polysulfate on hemostasis and platelets in vivo. Thromb Res 1982; 28: 389-99.
65. Cade JF, Buchanan MR, Boneu B i sur. A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation. Thromb Res 1984; 35: 613-25.
66. Kelton JG, Hirsh J. Bleeding associated with antithrombotic therapy. Semin Hematol 1980; 17: 259-91.
67. Levine MN, Hirsh J, Kelton JG. Heparin-induced bleeding. U: Lane DA, Lindahl U, ur. Heparin: Chemical and Biological Properties, Clinical Applications. London, UK: Edward Arnold, 1989, 517-32.
68. Morabia A. Heparin doses and major bleedings. Lancet 1986; 1: 1278-9.
69. Mant MJ, O'Brien BD, Thong KL i sur. Haemorrhagic complications of heparin therapy. Lancet 1977; 1: 1133-5.
70. Greinacher A, Potzsch B, Amiral J i sur. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994; 71: 247-51.
71. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998; 79: 1-7.
72. Warkentin TE. Heparin-induced thrombocytopenia: a clinicopathologic syndrome. Thromb Haemost 1999; 82 (suppl): 439-47.
73. Warkentin TE, Levine MN, Hirsh J i sur. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995; 332: 1330-5.
74. Sigel B, Edelstein AL, Savitch L, Hasty JH, Felix WRJr. Type of compression for reducing venous stasis. Arch Surg 1975; 110: 171-5.
75. Allan A, Williams JT, Bolton JP, Le Quesne LP. The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg 1983; 70: 172-4.
76. Turner GM, Cole SE, Brooks JH. The efficacy of graduated compression stockings in the prevention of deep vein thrombosis after major gynaecological surgery. BJOG 1984; 91: 588-91.
77. Clarke-Pearson DL, Synan IS, Hinshaw WM, Coleman RE, Creasman WT. Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obstet Gynecol 1984; 63: 92-8.
78. Clarke-Pearson DL, Synan IS, Dodge R, Soper JT, Berchuck A, Coleman RE. A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery. Am J Obstet Gynecol 1993; 168: 1146-54.
79. Davis J. Prevention, diagnosis, and treatment of venous thromboembolic complications of gynecologic surgery. Am J Obstet Gynecol 2001; 184: 759-75.